Spike Team S2 Ep 26

Pre-S2 (1-26)

5-01788 4 x 1mg Ask for price

Human IgG antibody Laboratories manufactures the spike team s2 ep 26 reagents distributed by Genprice. The Spike Team S2 Ep 26 reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact Spike S2. Other Spike products are available in stock. Specificity: Spike Category: Team Group: S2 Ep

True Blue

50mg Ask for price
Description: True Blue

True Blue

5mg Ask for price
Description: True Blue

Ac2-26 / Lipocortin-1 (2-26) / Annexin-1 (2-26) (Human) - Purified IgG Antibody

200 μg
EUR 604.8

FGF-21 (26-47) (Human) - Purified IgG Antibody

200 μg
EUR 604.8

JBS True Blue

300µl
EUR 13.7

JBS True Blue

300 µl
EUR 16
Description: JBS True Blue

True Blue Chloride

100mg
EUR 11200
Description: 71431-30-6

S2 Ep information

SARS-CoV-2 Spike S2-coupled Magnetic Beads

MBS-K018 2mg
EUR 2707.1
Description: SARS-CoV-2 Spike S2 Protein is expressed from human 293 cells (HEK293). It contains AA Ser 686 - Pro 1213 (Accession # QHD43416.1 (F817P, A892P, A899P, A942P,K986P,V987P)).

MERS-CoV Spike protein S2 (aa 726-1296) [His]

DAG-H10296 20µg
EUR 868.8

Spike Trimer (S1+S2), His-tag (SARS-CoV-2)

100728-1 100 µg
EUR 350
Description: Severe acute respiratory Coronavirus Spike trimer (S1+S2), with 682RRAR685>A, K986P, and V987P mutations, Genbank Accession No. MN908947, a.a. 1-1213, with a C-terminal His-tag, expressed in a HEK293 expression system. MW=139 kDa.

Spike Trimer (S1+S2), His-tag (SARS-CoV-2)

100728-2 1 mg
EUR 2995
Description: Severe acute respiratory Coronavirus Spike trimer (S1+S2), with 682RRAR685>A, K986P, and V987P mutations, Genbank Accession No. MN908947, a.a. 1-1213, with a C-terminal His-tag, expressed in a HEK293 expression system. MW=139 kDa.

Anti-MERS-CoV Spike Protein S2 Monoclonal Antibody

E-AB-V1299-100uL 100uL
EUR 415
Description: Unconjugated

Anti-MERS-CoV Spike Protein S2 Monoclonal Antibody

E-AB-V1299-50uL 50uL
EUR 250
Description: Unconjugated

Anti-MERS-CoV Spike Protein S2 Monoclonal Antibody

E-AB-V1299-each each Ask for price
Description: Unconjugated

Anti-MERS-CoV Spike Protein S2 Polyclonal Antibody

E-AB-V1300-100uL 100uL
EUR 415
Description: Unconjugated

Anti-MERS-CoV Spike Protein S2 Polyclonal Antibody

E-AB-V1300-50uL 50uL
EUR 250
Description: Unconjugated

Anti-MERS-CoV Spike Protein S2 Polyclonal Antibody

E-AB-V1300-each each Ask for price
Description: Unconjugated

Recombinant MERS-CoV Spike/S2 Protein (S2 Subunit, aa 726-1296, His Tag)

PKSV030243-100ug 100ug
EUR 1105
Description: MERS-CoV

Mouse Anti SARS-CoV-2 Spike (S2) Antibody (0018)

MAB12421-50 0.05
EUR 588.13
Description: Mouse monoclonal antibody against SARS-CoV-2 glycoprotein Spike S2.

Recombinant SARS-CoV Spike S2-His Recombinant Protein

PKSV030250-100ug 100ug
EUR 1105
Description: SARS

SARS-CoV-2 (COVID-19) Spike S2 Antibody [5E6]

PM-9429-002mg 0.02 mg
EUR 229.7
Description: Coronavirus disease 2019 (COVID-19), formerly known as 2019-nCoV acute respiratory disease, is an infectious disease caused by SARS-CoV-2, a virus closely related to the SARS virus (1). The disease is the cause of the 2019–20 coronavirus outbreak (2). The structure of 2019-nCoV consists of the following: a Spike protein (S), hemagglutinin-esterease dimer (HE), a membrane glycoprotein (M), an envelope protein (E) a nucleoclapid protein (N) and RNA. Coronavirus invades cells through Spike (S) glycoproteins, a class I fusion protein. It is the major viral surface protein that coronavirus uses to bind to the human cell surface receptor. It also mediates the fusion of host and viral cell membrane, allowing the virus to enter human cells and begin infection (3). The spike protein is the major target for neutralizing antibodies and vaccine development (4). The protein modeling suggests that there is strong interaction between Spike protein receptor-binding domain and its host receptor angiotensin-converting enzyme 2 (ACE2), which regulate both the cross-species and human-to-human transmissions of COVID-19 (5). The recent study has shown that the SARS-CoV-2 spike protein binds ACE2 with higher affinity than SARS-CoV spike protein (6).

SARS-CoV-2 (COVID-19) Spike S2 Antibody [5E6]

PM-9429-01mg 0.1 mg
EUR 594.26
Description: Coronavirus disease 2019 (COVID-19), formerly known as 2019-nCoV acute respiratory disease, is an infectious disease caused by SARS-CoV-2, a virus closely related to the SARS virus (1). The disease is the cause of the 2019–20 coronavirus outbreak (2). The structure of 2019-nCoV consists of the following: a Spike protein (S), hemagglutinin-esterease dimer (HE), a membrane glycoprotein (M), an envelope protein (E) a nucleoclapid protein (N) and RNA. Coronavirus invades cells through Spike (S) glycoproteins, a class I fusion protein. It is the major viral surface protein that coronavirus uses to bind to the human cell surface receptor. It also mediates the fusion of host and viral cell membrane, allowing the virus to enter human cells and begin infection (3). The spike protein is the major target for neutralizing antibodies and vaccine development (4). The protein modeling suggests that there is strong interaction between Spike protein receptor-binding domain and its host receptor angiotensin-converting enzyme 2 (ACE2), which regulate both the cross-species and human-to-human transmissions of COVID-19 (5). The recent study has shown that the SARS-CoV-2 spike protein binds ACE2 with higher affinity than SARS-CoV spike protein (6).

Mouse Anti SARS-CoV-2 Spike (S2) Antibody (CH1)

MAB12447-100 0.1
EUR 447.79
Description: Purified Monoclonal Antibody

Mouse Anti SARS-CoV-2 Spike (S2) Antibody (CH1)

MAB12447-500 0.5
EUR 1344.64
Description: Purified Monoclonal Antibody